Parabilis Medicines, Inc. Payments to Acquire Marketable Securities
Parabilis Medicines, Inc. (PBLS) reported Payments to Acquire Marketable Securities of $33.45 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-08-13
- 2026-06-30: Payments to Acquire Marketable Securities 6 month $33.45M.
- 2025-06-30: Payments to Acquire Marketable Securities 6 month $16.66M.
| Period end | Payments to Acquire Marketable Securities 6 month |
|---|---|
| 2026-06-30 | $33.45M 10-Q · filed 2026-08-13 |
| 2025-06-30 | $16.66M 10-Q · filed 2026-08-13 |